Cargando…

Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

Detalles Bibliográficos
Autores principales: Tang, Jing, Li, Yue, Wu, Jiazhu, Shen, Haorui, Yin, Hua, Liang, Jinhua, Wang, Li, Li, Jianyong, Xia, Yi, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491910/
https://www.ncbi.nlm.nih.gov/pubmed/37692509
http://dx.doi.org/10.1016/j.gendis.2023.04.012
_version_ 1785104162103492608
author Tang, Jing
Li, Yue
Wu, Jiazhu
Shen, Haorui
Yin, Hua
Liang, Jinhua
Wang, Li
Li, Jianyong
Xia, Yi
Xu, Wei
author_facet Tang, Jing
Li, Yue
Wu, Jiazhu
Shen, Haorui
Yin, Hua
Liang, Jinhua
Wang, Li
Li, Jianyong
Xia, Yi
Xu, Wei
author_sort Tang, Jing
collection PubMed
description
format Online
Article
Text
id pubmed-10491910
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Chongqing Medical University
record_format MEDLINE/PubMed
spelling pubmed-104919102023-09-10 Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma Tang, Jing Li, Yue Wu, Jiazhu Shen, Haorui Yin, Hua Liang, Jinhua Wang, Li Li, Jianyong Xia, Yi Xu, Wei Genes Dis Rapid Communication Chongqing Medical University 2023-05-18 /pmc/articles/PMC10491910/ /pubmed/37692509 http://dx.doi.org/10.1016/j.gendis.2023.04.012 Text en © 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Rapid Communication
Tang, Jing
Li, Yue
Wu, Jiazhu
Shen, Haorui
Yin, Hua
Liang, Jinhua
Wang, Li
Li, Jianyong
Xia, Yi
Xu, Wei
Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
title Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
title_full Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
title_fullStr Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
title_full_unstemmed Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
title_short Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
title_sort bortezomib depended on prdm1 and tp53 to exert therapeutic effect in activated b-cell-like diffuse large b-cell lymphoma
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491910/
https://www.ncbi.nlm.nih.gov/pubmed/37692509
http://dx.doi.org/10.1016/j.gendis.2023.04.012
work_keys_str_mv AT tangjing bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT liyue bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT wujiazhu bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT shenhaorui bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT yinhua bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT liangjinhua bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT wangli bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT lijianyong bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT xiayi bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma
AT xuwei bortezomibdependedonprdm1andtp53toexerttherapeuticeffectinactivatedbcelllikediffuselargebcelllymphoma